Literature DB >> 18087796

Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management.

S Del Prato1, A-M Felton, N Munro, R Nesto, P Zimmet, B Zinman.   

Abstract

Despite increasingly stringent clinical practice guidelines for glycaemic control, the implementation of recommendations has been disappointing, with over 60% of patients not reaching recommended glycaemic goals. As a result, current management of glycaemia falls significantly short of accepted treatment goals. The Global Partnership for Effective Diabetes Management has identified a number of major barriers that can prevent individuals from achieving their glycaemic targets. This article proposes 10 key practical recommendations to aid healthcare providers in overcoming these barriers and to enable a greater proportion of patients to achieve glycaemic goals. These include advice on targeting the underlying pathophysiology of type 2 diabetes, treating early and effectively with combination therapies, adopting a holistic, multidisciplinary approach and improving patient understanding of type 2 diabetes. Implementation of these recommendations should reduce the risk of diabetes-related complications, improve patient quality of life and impact more effectively on the increasing healthcare cost related to diabetes.

Entities:  

Year:  2007        PMID: 18087796

Source DB:  PubMed          Journal:  Int J Clin Pract Suppl        ISSN: 1368-504X


  2 in total

1.  Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia.

Authors:  Thamer A Alsulaiman; Hejab A Al-Ajmi; Saeed M Al-Qahtani; Intisar M Fadlallah; Nashwa E Nawar; Reem E Shukerallah; Sadaf R Nadeem; Nora M Al-Weheedy; Khalid A Al-Sulaiman; Adel A Hassan; Ayman A Shahin; Tamer M Kolib
Journal:  J Family Community Med       Date:  2016 Jan-Apr

2.  Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects.

Authors:  Antonella Napolitano; Sam Miller; Peter R Murgatroyd; Elizabeth Hussey; Robert L Dobbins; Edward T Bullmore; Derek J R Nunez
Journal:  J Clin Transl Endocrinol       Date:  2013-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.